Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-01-09 @ 5:24 PM
Study NCT ID:
NCT07139405
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-24
First Post:
2025-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT
Sponsor:
Myopharm Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-17
First Submit QC Date:
None
Study First Post Date:
2025-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-17
Last Update Post Date:
2025-08-24
Last Update Post Date Type:
ACTUAL